Upadacitinib

Upadacitinib (ABT-494) is a selective Janus kinase (JAK) 1 inhibitor, which is being studied for the treatment of several autoimmune disorders in the IC50 of 43 nM.

Price Not Available 1 mg Upadacitinib Supplier Page

Catalog Number	T7503
Alternative Name(s)	ABT-494
Research Area	JAK/STAT signaling\|\|\|Stem Cells\|\|\|Angiogenesis\|\|\|Chromatin/Epigenetic
Molecular Formula	C17H19F3N6O
CAS#	1310726-60-3
Purity	99.93%
SMILES	CC[C@@H]1CN(C[C@@H]1c1cnc2cnc3[nH]ccc3n12)C(=O)NCC(F)(F)F
Size	1 mg
Supplier Page	https://www.targetmol.com/compound/Upadacitinib
Additional Information	https://www.targetmol.com/datasheet/T7503